Refine Search
(20)
(66)
(95)
(96)

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018’, provides an overview of the Herpes Labialis (Oral Herpes) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Tularaemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tularaemia - Pipeline Review, H2 2018’, provides an overview of the Tularaemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tularaemia, complete wit...

Aspergillosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H2 2018’, provides an overview of the Aspergillosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Aspergillosis, com...

Cryptosporidiosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cryptosporidiosis - Pipeline Review, H2 2018’, provides an overview of the Cryptosporidiosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptospor...

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018’, provides an overview of the Progressive Multifocal Leukoencephalopathy pipeline landscape.

The report provides comprehensive information on...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018’, provides an overview of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline landscape.

The re...

Acinetobacter Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H2 2018’, provides an overview of the Acinetobacter Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Neisseria meningitidis Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H2 2018’, provides an overview of the Neisseria meningitidis Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018’, provides an overview of the Clostridium difficile Infections (Clostridium difficile Associated Disease) pipeline ...

Klebsiella pneumoniae Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H2 2018’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Rabies - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rabies - Pipeline Review, H2 2018’, provides an overview of the Rabies pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rabies, complete with analysis b...

Hepatitis A - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H2 2018’, provides an overview of the Hepatitis A pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis A, complete ...

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape.

The report provides comprehensive information on t...

Hepatitis D - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H2 2018’, provides an overview of the Hepatitis D pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis D, complete ...

Japanese Encephalitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H2 2018’, provides an overview of the Japanese Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ja...

Measles - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Measles - Pipeline Review, H2 2018’, provides an overview of the Measles pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Measles, complete with analysi...

Yellow Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H2 2018’, provides an overview of the Yellow Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Yellow Fever, comple...

Chikungunya Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chikungunya Fever - Pipeline Review, H2 2018’, provides an overview of the Chikungunya Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chikunguny...

Rotavirus Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H2 2018’, provides an overview of the Rotavirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rota...

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.

The report provides comprehensive information on the...

Pseudomonas aeruginosa Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pseudomonas aeruginosa Infections - Pipeline Review, H2 2018’, provides an overview of the Pseudomonas aeruginosa Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Human Parainfluenza Virus 3 Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Parainfluenza Virus 3 Infections - Pipeline Review, H2 2018’, provides an overview of the Human Parainfluenza Virus 3 Infections pipeline landscape.

The report provides comprehensive information on the the...

Hepatitis C - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H2 2018’, provides an overview of the Hepatitis C pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete ...

Herpes Zoster (Shingles) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H2 2018’, provides an overview of the Herpes Zoster (Shingles) pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

West Nile Virus Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘West Nile Virus Infections - Pipeline Review, H2 2018’, provides an overview of the West Nile Virus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Tetanus - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tetanus - Pipeline Review, H2 2018’, provides an overview of the Tetanus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tetanus, complete with analysi...

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2018’, provides an overview of the Influenza A Virus, H1N1 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Rhinovirus Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rhinovirus Infections - Pipeline Review, H2 2018’, provides an overview of the Rhinovirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rh...

Chlamydia Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chlamydia Infections - Pipeline Review, H2 2018’, provides an overview of the Chlamydia Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chla...

Influenzavirus B Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenzavirus B Infections - Pipeline Review, H2 2018’, provides an overview of the Influenzavirus B Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Schistosomiasis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Schistosomiasis - Pipeline Review, H2 2018’, provides an overview of the Schistosomiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Schistosomiasi...

Pyelonephritis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H2 2018’, provides an overview of the Pyelonephritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pyelonephritis, ...

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2018’, provides an overview of the Influenza A Virus, H5N1 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Hand, Foot and Mouth Disease - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hand, Foot and Mouth Disease - Pipeline Review, H2 2018’, provides an overview of the Hand, Foot and Mouth Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018’, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) pipeline landscape.

The report provides comprehensive info...

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018’, provides an overview of the Pseudomonas aeruginosa Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2018’, provides an overview of the Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline landscape.

The report provides comprehens...

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018’, provides an overview of the Epstein–Barr Virus (HHV-4) Infections pipeline landscape.

The report provides comprehensive information on the thera...

Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018’, provides an overview of the Lassa Fever (Lassa Hemorrhagic Fever) pipeline landscape.

The report provides comprehensive information on the thera...

Genital Herpes - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H2 2018’, provides an overview of the Genital Herpes pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Genital Herpes, ...

Coccidioidomycosis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Coccidioidomycosis - Pipeline Review, H2 2018’, provides an overview of the Coccidioidomycosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Coccidio...

Bacillary Dysentery (Shigellosis) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacillary Dysentery (Shigellosis) - Pipeline Review, H2 2018’, provides an overview of the Bacillary Dysentery (Shigellosis) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2018’, provides an overview of the Severe Acute Respiratory Syndrome (SARS) pipeline landscape.

The report provides comprehensive information on the...

Gonorrhea - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gonorrhea - Pipeline Review, H2 2018’, provides an overview of the Gonorrhea pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gonorrhea, complete with a...

Cryptococcosis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cryptococcosis - Pipeline Review, H2 2018’, provides an overview of the Cryptococcosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptococcosis, ...

Osteomyelitis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteomyelitis - Pipeline Review, H2 2018’, provides an overview of the Osteomyelitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteomyelitis, com...

Candidiasis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Candidiasis - Pipeline Review, H2 2018’, provides an overview of the Candidiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Candidiasis, complete ...

African Trypanosomiasis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H2 2018’, provides an overview of the African Trypanosomiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2018’, provides an overview of the Influenza A Virus, H3N2 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Anthrax - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anthrax - Pipeline Review, H2 2018’, provides an overview of the Anthrax pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anthrax, complete with analysi...